SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 3, 2002, Pages 305-310

A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma

(6) Perez Zincer, F a Olencki, T a,b Budd, G T a,b Peereboom, D a,b Elson, P b Bukowski, R M a,b

a LERNER RESEARCH INSTITUTE (United States)

b TAUSSIG CANCER INSTITUTE (United States)

Author keywords

(Gemzar ); Dose; Gemcitabine; Interferon 2b; Metastatic renal cell carcinoma

Indexed keywords

ANTIEMETIC AGENT; GEMCITABINE; HYDROMORPHONE; PARACETAMOL; RANITIDINE; RECOMBINANT ALPHA2B INTERFERON; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SCREENING; FEMALE; HUMAN; KIDNEY CARCINOMA; MALE; METASTASIS; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; DRUG RESISTANCE; HEMATOLOGIC DISEASE; KIDNEY TUMOR; MIDDLE AGED; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FEMALE; HEMATOLOGIC DISEASES; HUMAN; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; KIDNEY NEOPLASMS; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0036021242 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1016214030069 Document Type: Article

Times cited : (8)

References (32)

1
- 0033959520
- Cancer statistics 2000
- (2000) CA Cancer J Clin , vol.50 , pp. 7
- Greenlee, R.T.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0002688203
- Cancer of the kidney and ureter
- DeVita VT, Hellman S, Rosenberg SA (eds). Philadelphia, JB Lippincott Williams & Wilkins Co.
- (2001) Cancer: Principles and Practice of Oncology
- Linehan, W.M.¹ Zbar, B.² Bates, S.E.³ Zelefsky, M.J.⁴ Yang, J.C.⁵

3
- 0029053184
- A new protocol for the follow-up of renal cell carcinoma based on pathological stage
- (1995) J Urol , vol.154 , pp. 28-31
- Sandock, D.S.¹ Seftel, A.D.² Resnick, M.I.³

4
- 0028084421
- Patterns of failure following surgical resection of renal cell carcinoma: Implications for adjuvant local and systemic therapy
- (1994) J Clin Oncol , vol.12 , pp. 206-212
- Rabinovitch, R.A.¹ Zelefsky, M.J.² Gaynor, J.J.³ Fuks, Z.⁴

5
- 0022916252
- Renal cell carcinoma: Survival and prognostic factors
- (1986) Urology , vol.27 , pp. 291-301
- Golimbu, M.¹ Joshi, P.² Sperber, A.³ Tessler, A.⁴ Al-Askari, S.⁵ Morales, P.⁶

6
- 0022502967
- Prognostic factor in metastatic renal cell carcinoma
- (1986) J Urol , vol.136 , pp. 376-379
- Maldazys, J.D.¹ DeKemion, J.B.²

7
- 0028929682
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high dose recombinant interleukin-2 therapy
- (1995) J Clin Oncol , vol.13 , pp. 688-696
- Fyfe, G.¹ Fisher, R.I.² Rosenberg, S.A.³ Sznol, M.⁴ Parkinson, D.R.⁵ Lovie, A.C.⁶

8
- 0031406878
- High dose aldesleukin in renal cell carcinoma: Long term survival update
- (1997) Cancer J Sci Am , vol.3 , Issue.SUPPL. 1
- Fisher, R.J.¹ Rosenberg, S.A.² Sznol, M.³ Parkinson, D.R.⁴ Fyfe, G.⁵

9
- 0030931682
- Natural history and therapy of metastatic renal cell carcinoma: Role of interleukin 2
- (1997) Cancer , vol.80 , pp. 1198-1220
- Bukowski, R.M.¹

10
- 4243649544
- Emeryville (CA): Chiron Therapeutics
- (1992) Proleukin (aldesleukin for injection) package insert

11
- 0025360452
- Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: Correlation with the expression of a kidney-associated differentiation glycoprotein
- (1990) Cancer Res , vol.50 , pp. 4190-4194
- Nanus, D.M.¹ Pfeffer, L.M.² Bander, N.H.³ Bahri, S.⁴ Albino, A.P.⁵

12
- 0027173443
- Interferon alfa-2a in advanced renal cell carcinoma: Treatment results and survival in 159 patients with long-term follow-up
- (1993) J Clin Oncol , vol.11 , pp. 1368-1375
- Minasian, L.M.¹ Motzer, R.J.² Gluck, L.³ Mazumar, M.⁴ Vlamis, V.⁵ Krown, S.E.⁶

13
- 0026544875
- Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: Results of a European multi-center phase III study
- (1992) Ann Oncol , vol.3 , pp. 301-305
- Fossa, S.D.¹ Martinelli, G.² Otto, U.³ Schneider, G.⁴ Wander, H.⁵ Oberling, F.⁶ Baver, H.W.⁷ Achtnicht, U.⁸ Holdener, E.E.⁹

14
- 0025763734
- Vinblastine fails to improve response of renal cancer to interferon-alfa: High response rate in patients with pulmonary metastases
- (1991) J Clin Oncol , vol.9 , pp. 832-836
- Neidhart, J.A.¹ Anderson, S.A.² Harris, J.E.³ Rinehart, J.J.⁴ Lazlo, J.⁵ Dexus, F.H.⁶ Einhorn, L.H.⁷ Trump, D.L.⁸ Benedetto, P.W.⁹ Tuttle, R.L.¹⁰

15
- 0023296171
- Interferon treatment of renal cell carcinoma: Current status and future prospects
- (1987) Cancer , vol.59 , pp. 647-651
- Krown, S.E.¹

16
- 0033514050
- Interferon-γ and survival in metastatic renal carcinoma: Early results of a randomized controlled trial
- (1999) Lancet , vol.353 , pp. 14-17

17
- 7144227930
- Randomized human interleukin-2, recombinant alfa-2a, or both in metastatic renal cell carcinoma
- (1998) N Engl J Med , vol.338 , pp. 1272-1278
- Negrier, S.¹ Escudier, B.² Lasset, C.³ Douillard, J.Y.⁴ Savary, J.⁵ Chevreau, C.⁶ Ravaud, A.⁷ Mercatello, A.⁸ Peny, J.⁹ Masseau, M.¹⁰ Philip, T.¹¹ Tursz, T.¹²

18
- 0030049056
- Gemcitabine: A phase 11 study in patients with advanced renal cell cancer
- (1996) Cancer Chemother Pharmacol , vol.37 , pp. 491-495
- DeMulder, P.H.M.¹ Weissbach, L.² Jakse, G.³ Osieka, R.⁴ Blatter, J.⁵

19
- 0027231510
- Gemcitabine in advanced renal cell carcinoma
- (1993) Ann Oncol , vol.4 , pp. 331-332
- Mertens, W.C.¹ Eisenhauer, E.A.² Moore, M.³ Venner, P.⁴ Stewart, D.⁵ Muldal, A.⁶ Wong, D.⁷

20
- 0030748058
- Interferon-2a and gemcitabine (2′,2′-difluorodeoxycytidine) in adult and pediatric renal tumors
- (1997) Int J Oncol , vol.11 , pp. 623-627
- Rohde, D.¹ Geortz, M.² Hayn, N.K.³ Cremer, U.⁴ Jakse, G.⁵

21
- 0031814809
- The efficacy of 2′,2′-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines
- (1998) Int J Oncol , vol.12 , pp. 1361-1366
- Rohde, D.¹ Hayn, H.K.² Blatter, J.³ Jakse, G.⁴

22
- 0031865289
- The efficacy of 2′2′-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xeografts of human renal cell carcinoma
- (1988) Int J Oncol , vol.12 , pp. 1367-1372
- Rohde, D.¹ Goertz, M.² Blatter, J.³ Jakse, G.⁴

23
- 0031715098
- Treatment of renal cancer patients with gemcitabine (2′2′-difluorodeoxycytidine) and interferons: Antitumor activity and toxicity
- (1998) Oncology Reports , vol.5 , pp. 1555-1560
- Rohde, D.¹ Thiemann, D.² Wildberger, J.³ Wolff, J.⁴ Jakse, G.⁵

24
- 0009842839
- Interferon-alpha and 5-fluourouracil combination chemotherapy for metastatic renal cell cancer
- (1992) Interferons Cytokines , vol.1 , pp. 17-21
- Sella, A.¹ Amato, R.J.² Fitz, K.³

25
- 0027267811
- Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: Evidence for enhanced fluourouracil toxicity without pharmacokinetic perturbation
- (1993) J Clin Oncol , vol.11 , pp. 1609-1617
- Sparano, J.A.¹ Wadler, S.² Diasio, R.B.³ Zhang, R.⁴ Lu, Z.⁵ Schwartz, E.L.⁶ Einzig, A.⁷ Wiernik, P.H.⁸

26
- 0025945855
- Phase II trial of fluorouracil and recombinant alfa-2a interferon in patients with advanced colorectal carcinoma: An Eastern Cooperative Oncology Group study
- (1991) J Clin Oncol , vol.9 , pp. 1806-1810
- Wadler, S.¹ Lembersky, B.² Atkins, M.³ Kirkwood, J.⁴ Petrelli, N.⁵

27
- 0028176441
- Interferon-alfa, 5-FU and prednisone in metastatic renal cell carcinoma: A phase II study
- (1994) Ann Oncol , vol.5 , pp. 245-248
- Haarstad, H.¹ Jacobsen, A.B.² Schjølseth, S.A.³ Risberg, T.⁴ Fossa, S.D.⁵

28
- 0034074165
- Cytokine combinations: Therapeutic use in patients with advanced renal cell carcinoma
- (2000) Semin Oncol , vol.27 , pp. 204-212
- Bukowski, R.¹

29
- 0028206462
- The management of renal cell carcinoma
- (1994) Crit Rev Oncol Hematol , vol.16 , pp. 181-200
- Pittman, K.¹ Selby, P.²

30
- 4243807605
- Phase I study with gemcitabine and interferon alfa-2b in patients with advanced ovarian, pancreatic, kidney and NSCL cancer
- Abstr
- (1999) Proc Am Soc Clin Oncol , vol.18
- Fuxius, S.¹ Mross, K.² Mansouri, K.³ Unger, C.⁴

31
- 0025978216
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine
- (1991) J Clin Oncol , vol.9 , pp. 491-498
- Abbruzzese, J.L.¹ Grunewald, R.² Weeks, E.A.³ Gravel, D.⁴ Adams, T.⁵ Nowak, B.⁶ Mineishi, S.⁷ Tarassoff, P.⁸ Satterlee, W.⁹ Raber, M.N.¹⁰

32
- 0027946936
- Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study
- (1994) Invest New Drugs , vol.12 , pp. 111-119
- Pollera, C.F.¹ Ceribelli, A.² Crecco, M.³ Calabresi, F.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.